Human Immunoglobulin(pH4)(Hualan Biological Engineering）

人免疫球蛋白(pH4)（华兰生物工程股份有限公司）

Report date: 2022/03/03 17:33:51

Base Information

Drug NameHuman Immunoglobulin(pH4)(Hualan Biological Engineering）

Drug Alias Namehuman immunoglobulin (intravenous, immunoglobulin G deficiency/autoimmune diseases)Human Immunoglobulin(pH4) For Intravenous Injection (immunoglobulin G deficiency/autoimmune diseases), Hualan Biological Engineering

ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin

Mechanisms of ActionImmunoglobulin replacements

TargetsImmunoglobulin

Therapy Area/IndicationsAutoimmune DiseasesAgammaglobulinemia

Global Approved IndicationsAutoimmune DiseasesAgammaglobulinemia

Approved Indications in ChinaAutoimmune DiseasesAgammaglobulinemia

Original Approved Country/TerritoryMainland China

Original Approved Date1997/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesHualan Ankang Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHualan Biological Engineering Chongqing Co Ltd

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesAgammaglobulinemia

Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02